Added to YB: 2025-12-05
Pitch date: 2025-12-04
RMD [neutral]
ResMed Inc.
-1.07%
current return
Author Info
Best Anchor Stocks shares deep research on companies with long-term potential aThe Bear Cavend lower-than-average volatility. Sign up for the newsletter.
Company Info
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications to diagnose, treat, and manage respiratory disorders in the United States and internationally.
Market Cap
$35.9B
Pitch Price
$255.00
Price Target
N/A
Dividend
0.97%
EV/EBITDA
17.86
P/E
25.23
EV/Sales
6.73
Sector
Health Care Equipment and Supplies
Category
N/A
Resmed (RMD): The Sleep 'Monopoly'
RMD (pass): Sleep apnea CPAP monopolist w/ 80%+ market share after Phillips recall. Faces headwinds from Apnimed's Phase III oral pill (46.8% AHI reduction vs 6.8% placebo, NDA filing 2026) & GLP-1 weight loss drugs potentially reducing severe cases. Trades 26x P/E despite growth decel.
Read full article (8 min)